Risk for Heart Failure Higher in Young Adult Cancer Survivors
WEDNESDAY, June 7, 2023 (HealthDay News) — Young adult (YA) cancer survivors, especially those diagnosed with leukemia or those treated with anthracycline chemotherapy, face an increased risk for heart failure, according to a research letter publishe…
Learn MoreCan Some Cancer Patients Safely Skip Radiation Therapy? New Studies Say Yes
TUESDAY, June 6, 2023 (HealthDay News) — Radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials shows.One trial found that rectal cancer …
Learn MoreChinese Company May Help Ease U.S. Shortage of Cancer Drug
MONDAY, June 5, 2023 (HealthDay News) — With the United States facing a high number of drug shortages, a Chinese company may help to boost the supply of one in particular, the chemotherapy agent cisplatin.
The U.S. Food and Drug Administration is wor…
ASCO: Adding Pembrolizumab to Chemo Improves Survival in Cervical Cancer
THURSDAY, June 1, 2023 (HealthDay News) — For women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progression-free survival, accor…
Learn MoreCabozantinib Plus Nivolumab and Ipilimumab Increases PFS in Renal Cell Cancer
THURSDAY, May 11, 2023 (HealthDay News) — Cabozantinib plus nivolumab and ipilimumab yields significantly longer progression-free survival than treatment with cabozantinib plus nivolumab alone among patients with previously untreated, advanced renal-…
Learn MoreVenetoclax-Obinutuzumab With, Without Ibrutinib Superior in Leukemia
THURSDAY, May 11, 2023 (HealthDay News) — For fit patients with chronic lymphocytic leukemia (CLL), venetoclax-obinutuzumab with or without ibrutinib, is superior to chemoimmunotherapy as first-line treatment, according to a study published in the Ma…
Learn MoreCemiplimab + Chemotherapy Aids Quality of Life With Lung Cancer
WEDNESDAY, May 10, 2023 (HealthDay News) — Cemiplimab plus chemotherapy results in significant overall improvement in pain symptoms and delayed deterioration in cancer-related and lung cancer-specific symptoms and functions, according to a study publ…
Learn MoreUltrasound Breaches Blood-Brain Barrier, Helping Drugs Fight Tumors
WEDNESDAY, May 3, 2023 (HealthDay News) — Brain cancers are notoriously difficult to treat because most chemotherapy drugs can’t breach the blood-brain barrier, a microscopic layer of cells that protect the brain from toxins.But researchers now say t…
Learn MorePatient-Centered Approach Recommended for Oligometastatic NSCLC
TUESDAY, May 2, 2023 (HealthDay News) — A patient-centered, multidisciplinary approach is strongly recommended for decision-making regarding treatment for oligometastatic non-small cell lung cancer (NSCLC), according to a clinical practice guideline …
Learn MoreUna terapia combinada podría prevenir la recurrencia del cáncer tras una cirugía de hígado
LUNES, 24 de abril de 2023 (HealthDay News) — Una terapia combinada de dos medicamentos puede mejorar las probabilidades de supervivencia de las personas con un cáncer de hígado en etapa temprana, a través de unos ataques dirigidos contra las células…
Learn More